NASCIT is a special situations investment trust dedicated to active value and growth investments to achieve positive absolute returns for shareholders.

6 Stratton Street, London, W1J
Joined December 2021
#NAS top 10 investee #HSP announces that they have been awarded a 15-year contract providing logistics services to the UK Deposit Return Scheme londonstockexchange.com/en/n… Read more below ⤵️
We are delighted to announce that we have been awarded a 15-year contract for logistics services for the UK Deposit Return Scheme (DRS).
1
37
✔️#NAS top investee #OIG will be holding an investor presentation at 10.30am on Thursday 22 October 2026 The presentation will be an introduction to Oryx, an overview of fund performance, and the outlook of the Company
1
25
If you are interested in attending the investor presentation online or in-person, please register via [email protected] londonstockexchange.com/news…
14
☑️#NAS investee #PINE half year results ✔️ Underlying Revenue up 18.4% to £23.2m 📈 Recurring revenue increased to £19.6m in H1 FY26 (H1 FY25: £16.8m) ⭐ Strong strategic and operational progress, alongside continued growth
1
41
our growth and make the most of the significant market opportunity ahead, particularly in North America. None of the progress we have made would have been possible without the continued hard work and commitment of our associates, and I would like to thank them[...]"
1
1
8
☑️#NAS investee #SPI interim results - strong private payor growth and cash generation underpin robust performance ✔️Revenue remained broadly stable at £792.7m 📈Adjusted free cash flow up 35.3% to £20.7m
1
1
48
capacity and service development are helping us to gain market share and meet the UK’s growing healthcare needs. We were also proud to announce our strategic partnership with Team GB, making Spire Healthcare the Team’s exclusive Official Healthcare Services Partner. Together,...
1
21
these factors provide momentum for the second half, focused on strengthening our private patient proposition and delivering our transformation programme.” londonstockexchange.com/news…
9
#NAS top 10 investee #NIOX announces its interim results and tender offer 📈Tender offer today to return £12.5m to shareholders ✅Revenue of £24m 📊Gross margin at 71% reflecting higher mix of clinical sales 💷Cash of £16.8m with no debt
1
25
revenue and adjusted EBITDA in line with current consensus market expectations. Our strong balance sheet has enabled the Board to announce a Tender Offer today to return further cash to shareholders, while retaining the financial flexibility to continue investing in the...
1
7
business for future growth.” RNS: londonstockexchange.com/news…
2